These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 17026826)
1. Response to rituximab in patients with type II cryoglobulinemia. Bryce AH; Dispenzieri A; Kyle RA; Lacy MQ; Rajkumar SV; Inwards DJ; Yasenchak CA; Kumar SK; Gertz MA Clin Lymphoma Myeloma; 2006 Sep; 7(2):140-4. PubMed ID: 17026826 [TBL] [Abstract][Full Text] [Related]
2. Should rituximab be the rescue therapy for refractory mixed cryoglobulinemia associated with hepatitis C? Ahmed MS; Wong CF J Nephrol; 2007; 20(3):350-6. PubMed ID: 17557269 [TBL] [Abstract][Full Text] [Related]
3. Natural history and therapy of 66 patients with mixed cryoglobulinemia. Bryce AH; Kyle RA; Dispenzieri A; Gertz MA Am J Hematol; 2006 Jul; 81(7):511-8. PubMed ID: 16755564 [TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of rituximab in nonviral cryoglobulinemia vasculitis: data from the French Autoimmunity and Rituximab registry. Terrier B; Launay D; Kaplanski G; Hot A; Larroche C; Cathébras P; Combe B; de Jaureguiberry JP; Meyer O; Schaeverbeke T; Somogyi A; Tricot L; Zénone T; Ravaud P; Gottenberg JE; Mariette X; Cacoub P Arthritis Care Res (Hoboken); 2010 Dec; 62(12):1787-95. PubMed ID: 20740617 [TBL] [Abstract][Full Text] [Related]
5. Treatment with rituximab in patients with mixed cryoglobulinemia syndrome: results of multicenter cohort study and review of the literature. Ferri C; Cacoub P; Mazzaro C; Roccatello D; Scaini P; Sebastiani M; Tavoni A; Zignego AL; De Vita S Autoimmun Rev; 2011 Nov; 11(1):48-55. PubMed ID: 21821153 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of low-dose rituximab for mixed cryoglobulinemia. Visentini M; Granata M; Veneziano ML; Borghese F; Carlesimo M; Pimpinelli F; Fiorilli M; Casato M Clin Immunol; 2007 Oct; 125(1):30-3. PubMed ID: 17692572 [TBL] [Abstract][Full Text] [Related]
7. Long-term effects of anti-CD20 monoclonal antibody treatment of cryoglobulinaemic glomerulonephritis. Roccatello D; Baldovino S; Rossi D; Mansouri M; Naretto C; Gennaro M; Cavallo R; Alpa M; Costanzo P; Giachino O; Mazzucco G; Sena LM Nephrol Dial Transplant; 2004 Dec; 19(12):3054-61. PubMed ID: 15494358 [TBL] [Abstract][Full Text] [Related]
8. Rituximab may form a complex with IgMkappa mixed cryoglobulin and induce severe systemic reactions in patients with hepatitis C virus-induced vasculitis. Sène D; Ghillani-Dalbin P; Amoura Z; Musset L; Cacoub P Arthritis Rheum; 2009 Dec; 60(12):3848-55. PubMed ID: 19950292 [TBL] [Abstract][Full Text] [Related]
9. Rituximab as a therapeutic tool in severe mixed cryoglobulinemia. Roccatello D; Baldovino S; Rossi D; Giachino O; Mansouri M; Naretto C; Di Simone D; Francica S; Cavallo R; Alpa M; Napoli F; Sena LM Clin Rev Allergy Immunol; 2008 Feb; 34(1):111-7. PubMed ID: 18270864 [TBL] [Abstract][Full Text] [Related]
10. Improvement in psoriasis during rituximab therapy for mixed cryoglobulinemia type II. Moberg P; Charles JF; Respicio G; Venna SS; Rooney T Cutis; 2010 Sep; 86(3):133-5. PubMed ID: 21049729 [TBL] [Abstract][Full Text] [Related]
11. Rituximab in cryoglobulinemic peripheral neuropathy. Cavallo R; Roccatello D; Menegatti E; Naretto C; Napoli F; Baldovino S J Neurol; 2009 Jul; 256(7):1076-82. PubMed ID: 19263187 [TBL] [Abstract][Full Text] [Related]
12. A review of rituximab in cutaneous medicine. Scheinfeld N Dermatol Online J; 2006 Jan; 12(1):3. PubMed ID: 16638371 [TBL] [Abstract][Full Text] [Related]
13. Acute wrist and foot drop associated with hepatitis C virus related mixed cryoglobulinemia: rapid response to treatment with rituximab. Uppal R; Charles E; Lake-Bakaar G J Clin Virol; 2010 Jan; 47(1):69-71. PubMed ID: 19892591 [TBL] [Abstract][Full Text] [Related]
14. Rituximab treatment for glomerulonephritis in HCV-associated mixed cryoglobulinaemia: efficacy and safety in the absence of steroids. Quartuccio L; Soardo G; Romano G; Zaja F; Scott CA; De Marchi G; Fabris M; Ferraccioli G; De Vita S Rheumatology (Oxford); 2006 Jul; 45(7):842-6. PubMed ID: 16418196 [TBL] [Abstract][Full Text] [Related]